Aardvark Therapeutics News, Aardvark Therapeutics Quote, AARD Quote

Aardvark Therapeutics (NQ:AARD) Delayed: 1.01 -0.38 (27.34%)

Prev. Close

$1.39

Today 6M 1Y 5Y

Open

$1.25

52 Wk High

$0.45

52 Wk Low

$0.35

Day High

$1.39

Day Low

$0.93

P/E

N/A

EPS

$-0.27

Volume

4,131,466

Friends, Peers and Foes (?): ERAS, CCB, HUBG, SMPL, NEHC (more...)

ALERTS | RSS

Oct 26, 2026 01:40 PM Oppenheimer Downgrades Aardvark Therapeutics Inc (AARD) to Perform 'We Await Visibility'
Oct 26, 2026 08:52 AM Important Notice Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Power Solutions International, Inc. (NASDAQ: PSIX); and The Simply Good Foods Compan
Oct 26, 2026 06:58 AM Aardvark Therapeutics Inc (AARD) PT Lowered to $2 at H.C. Wainwright
Oct 23, 2026 08:39 AM Form 8-K Aardvark Therapeutics, For: Oct 23
Oct 23, 2026 07:01 AM Aardvark Therapeutics (AARD) Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Oct 23, 2026 07:00 AM Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Oct 22, 2026 04:17 PM Form 8-K Aardvark Therapeutics, For: Oct 22
Oct 22, 2026 04:05 PM FDA lifts clinical hold on Aardvark's ARD-101 for Prader-Willi
Oct 22, 2026 04:05 PM Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Oct 21, 2026 08:25 AM Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); and New Era Energy & Digital, Inc. (NASDA

Entities mentioned with AARD

View All Entities